Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited.
Blood Press. 2019 Jun;28(3):144-145
Authors: Kjeldsen SE, Narkiewicz K, Burnier M, Oparil S
PMID: 31076016 [PubMed - in process]
Source: Blood Pressure - Category: Hematology Tags: Blood Press Source Type: research